Chin Hur, MD, MPH

Associate Director, ITA Chin Hur
Associate Professor of Medicine, Harvard Medical School
Director of GI Health Outcomes Research, MGH Gastrointestinal Unit
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Fax: 617-726-9414
Location: Institute for Technology Assessment
Massachusetts General Hospital
101 Merrimac St., 10th FL
Boston, MA 02114

Dr. Hur received his bachelor degree from Columbia University, his MD and MPH degrees from Johns Hopkins University and completed his Internal Medicine residency at the Johns Hopkins Hospital. He subsequently completed his fellowship in Gastroenterology at the Beth Israel Deaconess Medical Center and then joined the faculty of the MGH Gastrointestinal Unit in 2002.

Dr. Hur's areas of clinical areas of interests include: gastroesophageal reflux disease (GERD), Barrett's esophagus, esophageal adenocarcinoma as well as gastrointestinal cancer screening. His research interest lies in outcomes research, specifically technology assessment with a focus on decision analysis and disease modeling, and the application of these methodologies to the management of cancers and pre-malignant states (e.g. dysplasia) in the gastrointestinal tract. This management includes the identification of clinical predictors, diagnostic algorithms, and the optimization of treatment.

Some of the specific projects that he has been involved with include a disease model of Barrett's Esophagus and Esophageal Cancer, an analysis of the impact of the implementation of Virtual Colonoscopies for colorectal cancer (CRC) screening and the possible role for chemoprevention in cancer care.



  • Heberle, C., Omidvari, A.-H., Ali, A., Kroep, S., Kong, C. Y., Inadomi, J. M., Rubenstein, J. H., Tramontano, A., Dowling, E., Hazelton, W. D., Luebeck, E. G., Lansdorp-Vogelaar, I. & Hur, C. (2017). Cost-Effectiveness of Screening Patients with Gastroesophageal Reflux Disease for Barrett's Esophagus With a Minimally Invasive Cell Sampling Device.. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, . [Online version]
  • Kroep, S., Heberle, C., Curtius, K., Kong, C. Y., Lansdorp-Vogelaar, I., Ali, A., Wolf, W. A., Shaheen, N. J., Spechler, S. J., Rubenstein, J. H., Nishioka, N. S., Meltzer, S. J., Hazelton, W. D., van Ballegooijen, M., Tramontano, A., Gazelle, G. S., Luebeck, E. G., Inadomi, J. M. & Hur, C. (2017). Impact of Radiofrequency Ablation Treatment of Barrett's Esophagus on Esophageal Adenocarcinoma: A Comparative Modeling Analysis.. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, . [Online version]
  • Yachimski, P. & Hur, C. (2016). Endoscopic therapy versus surgery for T1 colon cancer: defining model clinical practice.. Gastrointestinal endoscopy, 84, 995-996. [Online version]
  • Samur, S. K., Klebanoff, M., Banken, R., Pratt, D. S., Chapman, R., Ollendorf, D. A., Loos, A. M., Corey, K., Hur, C. & Chhatwal, J. (2016). Long-term Clinical Impact and Cost-Effectiveness of Obeticholic Acid for the Treatment of Primary Biliary Cholangitis.. Hepatology (Baltimore, Md.), . [Online version]
  • Chhatwal, J., Samur, S. K., Kues, B., Ayer, T., Roberts, M. S., Kanwal, F., Hur, C., Donnell, D. M. & Chung, R. T. (2016). Optimal Timing of Hepatitis C Treatment for Patients on the Liver Transplant Waiting List.. Hepatology (Baltimore, Md.), . [Online version]